147 related articles for article (PubMed ID: 8619646)
1. [-Tamoxifen and the endometrium: monitoring and evaluation of endometrial changes-].
Rageth JC; Bronz L; Granberg S
Arch Gynecol Obstet; 1995; 256 Suppl():S122-7. PubMed ID: 8619646
[No Abstract] [Full Text] [Related]
2. Tamoxifen for the prevention of breast cancer.
Greenspan EM
Am J Med; 1996 Jun; 100(6):665. PubMed ID: 8678089
[No Abstract] [Full Text] [Related]
3. [Results of the NSABP clinical trial for the prevention of cancer of the breast].
Namer M
Bull Cancer; 1998 Apr; 85(4):299. PubMed ID: 9752291
[No Abstract] [Full Text] [Related]
4. Indication of hysteroscopy in tamoxifen treated breast cancer patients.
Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR
J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527
[TBL] [Abstract][Full Text] [Related]
5. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
Hauth E; Libera H; Kimmig R; Forsting M
Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840
[TBL] [Abstract][Full Text] [Related]
6. Another view of tamoxifen.
Napoli M
Am J Nurs; 2001 Apr; 101(4):33. PubMed ID: 11301681
[No Abstract] [Full Text] [Related]
7. Tamoxifen. 'A big deal,' but a complex hand to play.
Marshall E
Science; 1998 Apr; 280(5361):196. PubMed ID: 9565527
[No Abstract] [Full Text] [Related]
8. [Morphologic endometrium changes with tamoxifen].
Dallenbach-Hellweg G; Hahn U; Schmidt D
Zentralbl Gynakol; 1996; 118(6):365-9. PubMed ID: 8768015
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen for the prevention of breast cancer in high-risk women.
Sweeney FW; Newton WP
J Fam Pract; 1999 Feb; 48(2):90-1. PubMed ID: 10037532
[No Abstract] [Full Text] [Related]
10. Tamoxifen for breast cancer prevention: safety warning.
Wooltorton E
CMAJ; 2002 Aug; 167(4):378-9. PubMed ID: 12197698
[No Abstract] [Full Text] [Related]
11. Tamoxifen: preventing breast cancer and placing the risk of deep vein thrombosis in perspective.
Goldhaber SZ
Circulation; 2005 Feb; 111(5):539-41. PubMed ID: 15699272
[No Abstract] [Full Text] [Related]
12. Endometrial changes with chronic tamoxifen use.
Loret de Mola JR
Curr Opin Obstet Gynecol; 1997 Jun; 9(3):160-4. PubMed ID: 9263698
[TBL] [Abstract][Full Text] [Related]
13. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
Semiglazov VF; Maksimov SIa; Bulgatova EA; Meshkova IE; Chepik OF; Berstein LM
Vopr Onkol; 2003; 49(2):198-204. PubMed ID: 12785205
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen and the endometrium.
Seidman JD; Kurman RJ
Int J Gynecol Pathol; 1999 Oct; 18(4):293-6. PubMed ID: 10542935
[No Abstract] [Full Text] [Related]
15. [-Results of ongoing breast cancer prevention studies-].
Jungi WF
Arch Gynecol Obstet; 1995; 256 Suppl():S116-21. PubMed ID: 8619644
[No Abstract] [Full Text] [Related]
16. Tamoxifen and cancer of the endometrium.
O'Connell G; Arnold A
CMAJ; 1993 Jun; 148(12):2113-4. PubMed ID: 8324682
[No Abstract] [Full Text] [Related]
17. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients.
Cheng WF; Lin HH; Torng PL; Huang SC
Gynecol Oncol; 1997 Aug; 66(2):233-7. PubMed ID: 9264568
[TBL] [Abstract][Full Text] [Related]
18. Indices of differential endometrial: myometrial growth may be used to improve the reliability of detecting endometrial neoplasia in women on tamoxifen.
Pepper JM; Oyesanya OA; Dewart PJ; Howell A; Seif MW
Ultrasound Obstet Gynecol; 1996 Dec; 8(6):408-11. PubMed ID: 9014281
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen's trials and tribulations.
Marshall E
Science; 1995 Nov; 270(5238):910. PubMed ID: 7481787
[No Abstract] [Full Text] [Related]
20. [Endometrial cancer and tamoxifen. Discussion apropos of a series of cases].
Sasco AJ; Ah-Song R; Gendre I; Zlatoff P; Bobin JY; Hallonet P; Leduc B
Bull Cancer; 1997 Jan; 84(1):51-60. PubMed ID: 9180860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
